Iberia Pharmaceuticals India Private Limited

Pharmaceutical trading company based in Delhi, established in 2013.

2013 | South West Delhi, Delhi (India) | Active
Last Updated:

Iberia Pharmaceuticals India Profile

Key Indicators

  • Authorised Capital ₹ 1.01 Cr
  • Paid Up Capital ₹ 1.74 M
  • Company Age 12 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 5.24 Cr
  • Revenue Growth 53.87%
  • Profit Growth 361.04%
  • Ebitda 234.68%
  • Net Worth 125.94%
  • Total Assets -29.65%

About Iberia Pharmaceuticals India

Iberia Pharmaceuticals India Private Limited (IPIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 March 2013 and has a history of 12 years and one month. Its registered office is in South West Delhi, Delhi, India.

The Corporate was formerly known as Satnam Medical Agencies Private Limited. The Company is engaged in the Trading Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.01 Cr and a paid-up capital of Rs 1.74 M.

The company currently has active open charges totaling ₹5.24 Cr.

Rishab Jain, Nitin Jain, and Saurav Ojha serve as directors at the Company.

Company Details

  • Location

    South West Delhi, Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232DL2013PTC250040

  • Company No.

    250040

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    30 Mar 2013

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Trading
Company report

Iberia Pharmaceuticals India Private Limited

Explore comprehensive data for Iberia Pharmaceuticals India Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Iberia Pharmaceuticals India?

Board Members (3)

NameDesignationAppointment DateStatus
Rishab Jain Country flag representing In Director 02-May-2021Current
Nitin Jain Country flag representing In Director 30-Mar-2013Current
Saurav Ojha Country flag representing In Director 30-Sep-2023Current

Financial Performance of Iberia Pharmaceuticals India.

Iberia Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53.87% increase. The company also saw a substantial improvement in profitability, with a 361.04% increase in profit. The company's net worth Soared by an impressive increase of 125.94%.

Iberia Pharmaceuticals India revenue growth over time
Iberia Pharmaceuticals India profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
53.87%
Revenue from Operations
52.09%
Total Assets
-29.65%
Profit or Loss
361.04%
Net Worth
125.94%
EBITDA
234.68%

What is the Ownership and Shareholding Structure of Iberia Pharmaceuticals India?

In 2023, Iberia Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹5.24 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 4.99 Cr
  • Hdfc Bank Limited : 0.25 Cr

Latest Charge Details

DateLenderAmountStatus
27 Dec 2023Others₹4.99 CrOpen
27 Dec 2023Hdfc Bank Limited₹2.51 MOpen

How Many Employees Work at Iberia Pharmaceuticals India?

Unlock and access historical data on people associated with Iberia Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Iberia Pharmaceuticals India Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Iberia Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iberia Pharmaceuticals India's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Iberia Pharmaceuticals India

Recent activity within the organization

  • Charges

    A charge with Others amounted to Rs. 4.99 Cr with Charge ID 100850475 was registered on 27 Dec 2023.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.25 Cr with Charge ID 100865259 was registered on 27 Dec 2023.

  • Annual General Meeting

    Iberia Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Director Appointment

    Saurav Ojha was appointed as a Director was appointed as a Director on 30 Sep 2023 & has been associated with this company since 1 year 7 months .

  • Balance Sheet

    Iberia Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

  • Director Appointment

    Rishab Jain was appointed as a Director was appointed as a Director on 02 May 2021 & has been associated with this company since 4 years 15 days .

Frequently asked questions

  • What is the Incorporation or founding date of Iberia Pharmaceuticals India Private Limited?

    Iberia Pharmaceuticals India Private Limited was incorporated on 30 Mar 2013.

  • What is authorized share capital and paid-up capital of Iberia Pharmaceuticals India Private Limited?

    The authorized share capital of Iberia Pharmaceuticals India Private Limited is ₹ 1.01 Cr and paid-up capital is ₹ 1.74 M.

  • Who are the current board members & directors of Iberia Pharmaceuticals India Private Limited?

    Currently 3 directors are associated with Iberia Pharmaceuticals India Private Limited.

    • Rishab Jain
    • Nitin Jain
    • Saurav Ojha

  • What is the registered address of Iberia Pharmaceuticals India Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Iberia Pharmaceuticals India Private Limited is Property No. 4 Block-C First Floor Sector-8, Dwarka India, New Delhi, 110077.

  • What is the corporate identification number (CIN) and company number of Iberia Pharmaceuticals India Private Limited?

    The corporate identification number (CIN) of Iberia Pharmaceuticals India Private Limited is U24232DL2013PTC250040 and the company number is 250040 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Iberia Pharmaceuticals India Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Iberia Pharmaceuticals India Private Limited has risen by 53.87%.

  • What change has been observed in the net worth of Iberia Pharmaceuticals India Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Iberia Pharmaceuticals India Private Limited has experienced an upsurge of 125.94%.

  • What are the total open charges for Iberia Pharmaceuticals India Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Iberia Pharmaceuticals India Private Limited amount to ₹ 5.24 Cr.

  • When was the last Balance Sheet of Iberia Pharmaceuticals India Private Limited filed with the ROC?

    The most recent Balance Sheet for Iberia Pharmaceuticals India Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Other Wholesale